(Bloomberg) -- Big Alcohol and Big Tobacco have garnered a formidable reputation in the lobbying arena over the years. Big Pot is now looking for a piece of the action.
Disparate players from the cannabis industry banded together last week in a new organization, called the U.S. Cannabis Council, to push their interests in Washington, D.C., and state capitals. Meanwhile, Marlboro maker Altria Group Inc. and Corona beer producer Constellation Brands Inc. are becoming more prominent in advocating for their marijuana investments.
The efforts put muscle behind an industry that has grassroots momentum but lacks a unified voice. Given how many causes it’s rallying behind -- proffering cannabis as a solution to problems as diverse as the opioid epidemic, the pain of chronic diseases, pandemic-related unemployment and America’s racial divide -- the lobbying machine is poised to become a major player.
There’s plenty of room to grow. Last year, just $4 million was spent on marijuana lobbying, according to Open Secrets. That’s measly compared to the $27 million that was spent by tobacco lobbyists, and roughly $30 million from the beer, wine and liquor industry.
The new lobbying group, announced Feb. 8, brings together a diverse group. There are large multistate operators like Canopy Growth Corp. and Curaleaf Holdings Inc., a trade association for hemp and special interest groups supporting veterans and racial minorities. Law firms Husch Blackwell and Vicente Sederberg are also founding members, along with Pax Labs Inc., the company that separated from Juul Labs Inc. and now specializes in cannabis vaporizers.
The lobbying organization gives the industry one voice on its most important issues, like access to banking, tax relief and the long-sought after goal of national legalization.
Read More: With Democrats in Control, Investors Are High on Cannabis
“This is an important milestone for the industry,” Canopy Chief Executive Officer David Klein said during his company’s recent earnings call. “The overwhelming feedback we heard in our conversations with elected officials and regulatory bodies is how disjointed and fragmented the industry currently is.”
The announcement came on the heels of other notable news: Altria, the tobacco giant that already had a 45% stake in cannabis company Cronos Labs, has officially entered the lobbying fray for marijuana.
Virginia records show that Elizabeth Rafferty, director of government relations for Williams Mullen, is registered to lobby on behalf of Altria on issues related to “the responsible and equitable regulation of cannabis sales in Virginia.” It’s the first state in which the company is registered to lobby on cannabis.
Rafferty wouldn’t discuss her role when reached by phone, and an Altria representative didn’t share details, either. But the company indicated that it’s fully onboard with the marijuana industry’s highest aim.
Altria “supports the federal legalization of cannabis under an appropriate regulatory framework,” spokesman George Parman said in an emailed statement. “As a stakeholder in this industry, we intend to work with policy makers and regulators to support a transparent, responsible and equitable operating environment for the sale of cannabis.”
Of course, consumer companies aren’t entirely new to pot lobbying. In an interview after Canopy’s earnings, Klein discussed just how deep Constellation Brands’ involvement in the company’s efforts to enter the U.S. market have run. The beer maker is sitting alongside Canopy in discussions with banks, stock exchanges and, yes, government officials.
“Our government relations teams are very closely connected,” he said. “We share an office in Washington, D.C.”
NUMBER OF THE WEEK
- $100 million: The amount that a single, undisclosed institutional investor spent to buy around 3.1 million shares of Green Thumb Industries.
QUOTE OF THE WEEK
“Are people sticking it to the man on this? Lazy shorts are lazy shorts. I think lazy shorts and catalysts are the same recipe that worked at Gamestop, and so, here we are,” said Tim Seymour, of Amplify Seymour Cannabis ETF, on the wild ride up, and then down, that cannabis stocks such as Tilray experienced this week after becoming the next target of Reddit chatter.
WHAT YOU NEED TO KNOW
- Leaders of some of the marijuana industry’s biggest companies have joined a Twitter movement that pushes back against the Reddit mania that’s taken pot stocks on a wild ride.
- Tilray Inc. shares lost around half their value Thursday, the most ever, as a Reddit-inspired push into cannabis stocks quickly unraveled.
- The top exchange-traded funds in the early weeks of 2021 all track the cannabis industry.
- With the support of Constellation Brands, Canopy expects to gain broad access to the U.S. market this year.
- Connecticut Governor Ned Lamont said he would introduce legislation describing his plans to legalize recreational marijuana by May 2022.
- Wisconsin Governor Tony Evers said he hopes to collect $166 million a year in taxes under a plan to legalize recreational marijuana.
- With cannabis companies unable to use federal bankruptcy court, MedMen Enterprises Inc. is turning to alternative remedies for its financial woes.
- MedMen reports second-quarter results after the market closes.
©2021 Bloomberg L.P.
BNN Bloomberg Picks
Self-described Bitcoin creator must pay US$100M in lawsuit
Shock to crypto daredevils joins list of scary omens in markets
From bust to boom: N.L. oil workers finding new careers in province's tech sector
Tax-loss selling now could bring further tax savings in 2022
One-in-four Canadians overspent on Black Friday and Cyber Monday: Poll
Food prices climb closer to record, boosting inflation angst